胆囊癌新辅助治疗研究进展  

Research progress in neoadjuvant therapy for gallbladder cancer

作　　者：何凯(综述) 环韵峰 胡晟 陈璐 王关振 邵峰 张小文(校审)[1] HE Kai;HUAN Yunfeng;HU Sheng;CHEN Lu;WANG Guanzhen;SHAO Feng;ZHANG Xiaowen(Department of Hepatobiliary Pancreatic Surgery,the Second Affiliated Hospital of Kunming Medical University,Kunming,Yunnan 650101,China)

机构地区：[1]昆明医科大学第二附属医院肝胆胰外科,云南昆明650101

出　　处：《现代医药卫生》2023年第13期2278-2283,共6页Journal of Modern Medicine & Health

基　　金：云南省万人计划“名医”培养基金项目(云人社[2018]73号)。

摘　　要：胆囊癌早期诊断率低,且易复发及转移。近年来,新辅助治疗因有望使局部进展期或不可切除胆囊癌患者获得手术机会,从而改善预后。目前,关于胆囊癌新辅助治疗的适应证及治疗方案尚未达成共识,该文对胆囊癌新辅助治疗的现状及研究进展进行了综述,以期为临床提供一些思路。Early diagnosis rate of gallbladder cancer is low,and it is prone to recurrence and metastasis.In recent years,neoadjuvant therapy has the potential to provide surgical opportunities for patients with locally advanced or unresectable gallbladder cancer,thereby improving prognosis.At present,there is no consensus on the indications and treatment plans of neoadjuvant therapy for gallbladder cancer.The article reviews the current status and research progress of neoadjuvant therapy for gallbladder cancer,in order to provide some ideas for clinical practice.

关 键 词：胆囊癌 新辅助治疗 预后 综述 

分 类 号：R735.8[医药卫生—肿瘤]